![Lucy Edwardes Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lucy Edwardes Jones
Direktor/Vorstandsmitglied bei Maxion Therapeutics Ltd.
Aktive Positionen von Lucy Edwardes Jones
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Private Equity Investor | 01.01.2020 | - |
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 21.09.2023 | - |
Karriereverlauf von Lucy Edwardes Jones
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Finance |
Maxion Therapeutics Ltd.
![]() Maxion Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Lucy Edwardes Jones
- Erfahrung